Suchergebnisse - "Flanagan, Emma"

PubPharm (5)

1

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Flanagan, E. | Prentice, R. | Wright, E. | +9

CommentIn: Aliment Pharmacol Ther. 2022 Feb;55(4):495-496. - PMID 35092058

2

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

3

Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography

enthalten in: Journal of Crohn's & colitis | 2020

von Flanagan, E. | Wright, E. | Begun, J. | +5

4

Vedolizumab for ulcerative colitis : Real world outcomes from a multicenter observational cohort of Australia and Oxford

enthalten in: World journal of gastroenterology | 2020

von Pulusu, S. | Srinivasan, A. | Krishnaprasad, K. | +22

5

Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis

enthalten in: Journal of nephrology | 2019

von Chinnadurai, R. | Flanagan, E. | Kalra, P.

1
[1]